Authors: THORSSON L DAHLSTROM K EDSBACKER S KALLEN A PAULSON J WIREN JE

Citation: L. Thorsson et al., PHARMACOKINETICS AND SYSTEMIC EFFECTS OF INHALED FLUTICASONE PROPIONATE IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 43(2), 1997, pp. 155-161

Authors: EDSBACKER S LARSSON P NILSSON M WIREN JE

Citation: S. Edsbacker et al., BUDESONIDE CONTROLLED ILEAL RELEASE (CIR) CAPSULES AFFECT PLASMA-CORTISOL LESS-THAN PREDNISOLONE, Gastroenterology, 108(4), 1995, pp. 814-814

Authors: NILSSON M EDSBACKER S LARSSON P WIREN JE

Citation: M. Nilsson et al., DOSE-PROPORTIONAL KINETICS OF BUDESONIDE CONTROLLED ILEAL RELEASE CAPSULES, Gastroenterology, 108(4), 1995, pp. 885-885

Authors: ANDERSSON N KLINT S RANDWALL G WIREN JE

Citation: N. Andersson et al., EQUIPOTENCY OF BUDESONIDE AND FLUTICASONE PROPIONATE IN THE VASOCONSTRICTION ASSAY, Clinical and experimental allergy, 24(2), 1994, pp. 182-182

Authors: FORMGREN H SJOKVIST A STAHL E WIREN JE

Citation: H. Formgren et al., TERBUTALINE IN COPD COMPARISON BETWEEN TURBUHALER(R) AND CHLOROFLUOROCARBON (CFC) INHALER, Lung, 172(5), 1994, pp. 271-280

Authors: ROSBERG B SCHRODER C NYBERG L ROSENBORG J WIREN JE

Citation: B. Rosberg et al., BAMBUTEROL AND TERBUTALINE IN HUMAN CEREBROSPINAL-FLUID AND PLASMA, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 147-150